Mark Zuckerberg and Dr. Priscilla Chan announced that CZI is shifting its focus toward combining biology and AI under a new Biohub division, integrating its acquisition of EvolutionaryScale to accelerate disease prevention and treatment. The move reflects a strategic transition away from education initiatives toward AI-driven biomedical research.
